The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical status and controversies

How to predict recovery after cell therapy in post-MI patients?

EuroIntervention Supplements (2007) 2 (Supplement B) B60-B65.

1. Department of Cardiology, University Hospital, Clermont-Ferrand, France; 2. Poznan University School of Medical Sciences, Cardiac and Rehabilitation Hospital, Kowanowko, Poland

Cell replacement therapy has been intensively investigated as a new tool in patients with ischaemic heart disease (IHD) and in particular in those treated by reperfusion therapy in the acute of phase of myocardia

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Persistent angina in "no option" patients with advanced coronary artery disease